NASDAQ:SGRY

Surgery Partners - SGRY Stock Forecast, Price & News

$31.65

-0.19 (-0.60%)

(As of 03/23/2023 04:00 PM ET)

Add

Compare

Today's Range: $31.11
▼
$32.75
50-Day Range: $30.11
▼
$35.94
52-Week Range: $20.46
▼
$63.87

Volume: 357,048 shs
Average Volume: 688,311 shs
Market Capitalization: $3.99 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $42.00

Institutional Ownership

Surgery Partners MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.71 Rating Score
Upside/Downside: 34.3% Upside
$42.00 Price Target
Short Interest: Bearish
8.12% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.53
Based on 3 Articles This Week
Insider Trading: Selling Shares
$2.41 M Sold Last Quarter
Proj. Earnings Growth: 65.00%
From $0.40 to $0.66 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.13 out of 5 stars

Medical Sector

618th out of 986 stocks

General Medical & Surgical Hospitals Industry

5th out of 5 stocks

3.4

Analyst's Opinion

Consensus Rating
Surgery Partners has received a consensus rating of Buy. The company's average rating score is 2.71, and is based on 5 buy ratings, 2 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $42.00, Surgery Partners has a forecasted upside of 34.3% from its current price of $31.28.
Amount of Analyst Coverage
Surgery Partners has only been the subject of 3 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
8.12% of the float of Surgery Partners has been sold short.
Short Interest Ratio / Days to Cover
Surgery Partners has a short interest ratio ("days to cover") of 7.
Change versus previous month
Short interest in Surgery Partners has recently decreased by 1.06%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
Surgery Partners does not currently pay a dividend.
Dividend Growth
Surgery Partners does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for SGRY.

2.5

News and Social Media Coverage

News Sentiment
Surgery Partners has a news sentiment score of 0.53. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.34 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Surgery Partners this week, compared to 2 articles on an average week.
Search Interest
Only 3 people have searched for SGRY on MarketBeat in the last 30 days. This is a decrease of -63% compared to the previous 30 days.
MarketBeat Follows
Only 2 people have added Surgery Partners to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Surgery Partners insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,410,750.00 in company stock.
Percentage Held by Insiders
Only 3.30% of the stock of Surgery Partners is held by insiders.

1.9

Earnings and Valuation

Earnings Growth
Earnings for Surgery Partners are expected to grow by 65.00% in the coming year, from $0.40 to $0.66 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Surgery Partners is -53.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Surgery Partners is -53.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Surgery Partners has a P/B Ratio of 1.34. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Surgery Partners (NASDAQ:SGRY) Stock

Surgery Partners, Inc. is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. It operates through the following business segments: Surgical Facility Services, Ancillary Services, and Optical Services. The Surgical Facility Services segment consists of the operation of ambulatory surgery centers and surgical hospitals, including anesthesia services of the company. The Ancillary Services segment operates a diagnostic laboratory and multi-specialty physician practices. The Optical Services segment involves an optical laboratory and an optical products group purchasing organization. The company was founded in 2004 and is headquartered in Brentwood, TN.

Receive SGRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter.

SGRY Stock News Headlines

March 18, 2023 | benzinga.com

Surgery Partners Chief Growth Officer Sold $172K In Company Stock

March 18, 2023 | americanbankingnews.com

Insider Selling: Surgery Partners, Inc. (NASDAQ:SGRY) CEO Sells 10,300 Shares of Stock

March 23, 2023 | Oxford Club (Ad)

My No. 1 dividend stock for a LIFETIME of income.

Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century! I think it's a crying shame folks don't know how powerful dividends are.

March 17, 2023 | americanbankingnews.com

Bradley R. Owens Sells 1,669 Shares of Surgery Partners, Inc. (NASDAQ:SGRY) Stock

March 16, 2023 | benzinga.com

Surgery Partners Recent Insider Activity

March 7, 2023 | msn.com

Surgery Partners's Return On Capital Employed Insights

March 6, 2023 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS), Gilead Sciences (GILD) and Surgery Partners (SGRY)

March 4, 2023 | benzinga.com

Surgery Partners Insider Trades Send a Signal

March 23, 2023 | Behind the Markets (Ad)

BREAKING: Tiny biotech successfully treats blindness

There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.

March 3, 2023 | msn.com

Surgery Partners' Fourth-Quarter Performance to Give Investors Confidence but Outlook Could 'Prove Conservative,' RBC Says

March 3, 2023 | finance.yahoo.com

Surgery Partners, Inc. (NASDAQ:SGRY) Q4 2022 Earnings Call Transcript

March 2, 2023 | finance.yahoo.com

Those who invested in Surgery Partners (NASDAQ:SGRY) three years ago are up 180%

March 1, 2023 | finance.yahoo.com

Surgery Partners (SGRY) Q4 Earnings and Revenues Top Estimates

March 1, 2023 | msn.com

Surgery Partners Non-GAAP EPS of $0.27 beats by $0.09, revenue of $707.1M beats by $18.45M

March 1, 2023 | finance.yahoo.com

Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2022 Results; Sets 2023 Guidance

February 28, 2023 | finance.yahoo.com

Surgery Partners Stock Gets Technical Rating Upgrade

February 23, 2023 | nasdaq.com

SGRY Makes Notable Cross Below Critical Moving Average

February 23, 2023 | uk.finance.yahoo.com

Surgery Partners, Inc. (SGRY)

February 9, 2023 | finance.yahoo.com

Surgery Partners, Inc. Announces Fourth Quarter 2022 Earnings Release Date and Conference Call Details

January 25, 2023 | benzinga.com

Surgery Partners Stock (NASDAQ:SGRY), Quotes and News Summary

January 18, 2023 | markets.businessinsider.com

Analyst Expectations for Surgery Partners's Future

January 11, 2023 | msn.com

Surgery Partners reaffirms FY22 guidance

January 9, 2023 | finance.yahoo.com

Surgery Partners, Inc. Reaffirms 2022 Full Year Guidance

December 27, 2022 | finance.yahoo.com

Private equity firms account for 48% of Surgery Partners, Inc.'s (NASDAQ:SGRY) ownership, while institutions account for 41%

December 6, 2022 | msn.com

Surgery Partners's Return On Capital Employed Overview

November 25, 2022 | benzinga.com

Board Member At This Health Care Company Buys $225.00M of Stock

November 24, 2022 | benzinga.com

225.00M Reasons To Be Bullish On Surgery Partners Stock

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive SGRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter.

SGRY Company Calendar

Last Earnings: 3/01/2023
Today: 3/23/2023
Next Earnings (Estimated): 5/02/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: General medical & surgical hospitals
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:SGRY
CUSIP: N/A
CIK: 1638833
Web: www.surgerypartners.com
Phone: (615) 234-5900
Fax: 615-234-5998
Employees: 12,200
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $42.00
High Stock Price Forecast: $56.00
Low Stock Price Forecast: $35.00
Forecasted Upside/Downside: +31.9%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.71
Research Coverage: 7 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.58)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 79.60
P/E Growth: N/A
Net Income: $-54,600,000.00
Net Margins: -2.15%
Pretax Margin: 4.34%
Return on Equity: -0.14%
Return on Assets: -0.05%

Debt

Debt-to-Equity Ratio: 0.87
Current Ratio: 1.87
Quick Ratio: 1.72

Sales & Book Value

Annual Sales: $2.54 billion
Price / Sales: 1.58
Cash Flow: $0.89 per share
Price / Cash Flow: 35.73
Book Value: $23.35 per share
Price / Book: 1.36

Miscellaneous

Outstanding Shares: 126,030,000
Free Float: 121,869,000
Market Cap: $4.01 billion
Optionable: Optionable
Beta: 2.73

Key Executives

J. Eric Evans
Chief Executive Officer & Director

David T. Doherty
Chief Financial Officer & Executive Vice President

Varun Gadhok
Chief Information Officer & Senior Vice President

Roxanne Womack
Chief Compliance Officer & Senior Vice President

Jennifer B. Baldock
Secretary, Chief Administrative Officer & EVP

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

SGRY Stock - Frequently Asked Questions

Should I buy or sell Surgery Partners stock right now?: 7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SGRY shares.
View SGRY analyst ratings or view top-rated stocks.
What is Surgery Partners' stock price forecast for 2023?: 7 equities research analysts have issued twelve-month target prices for Surgery Partners' shares. Their SGRY share price forecasts range from $35.00 to $56.00. On average, they expect the company's share price to reach $42.00 in the next year. This suggests a possible upside of 31.9% from the stock's current price.
View analysts price targets for SGRY or view top-rated stocks among Wall Street analysts.
How have SGRY shares performed in 2023?: Surgery Partners' stock was trading at $27.86 at the beginning of the year. Since then, SGRY stock has increased by 14.3% and is now trading at $31.84.
View the best growth stocks for 2023 here.
When is Surgery Partners' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 2nd 2023.
View our SGRY earnings forecast.
How were Surgery Partners' earnings last quarter?: Surgery Partners, Inc. (NASDAQ:SGRY) issued its quarterly earnings results on Wednesday, March, 1st. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.06. The firm had revenue of $707.10 million for the quarter, compared to analyst estimates of $688.34 million. Surgery Partners had a negative net margin of 2.15% and a negative trailing twelve-month return on equity of 0.14%.
What ETFs hold Surgery Partners' stock?: ETFs with the largest weight of Surgery Partners (NASDAQ:SGRY) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS), iShares U.S. Healthcare Providers ETF (IHF), First Trust Mid Cap Growth AlphaDEX Fund (FNY), Inspire Small/Mid Cap ETF (ISMD), Vanguard Health Care ETF (VHT) and Fidelity MSCI Health Care Index ETF (FHLC).Fidelity Blue Chip Growth ETF (FBCG) and
What guidance has Surgery Partners issued on next quarter's earnings?: Surgery Partners issued an update on its FY 2023 earnings guidance on Wednesday, March, 1st. The company provided EPS guidance of for the period. The company issued revenue guidance of $2.75B-, compared to the consensus revenue estimate of $2.81 billion.
What is Eric Evans' approval rating as Surgery Partners' CEO?: 7 employees have rated Surgery Partners Chief Executive Officer Eric Evans on Glassdoor.com. Eric Evans has an approval rating of 86% among the company's employees.

What other stocks do shareholders of Surgery Partners own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Surgery Partners investors own include Sorrento Therapeutics (SRNE), Rigel Pharmaceuticals (RIGL), Ardelyx (ARDX), Glu Mobile (GLUU), Ocular Therapeutix (OCUL), Sangamo Therapeutics (SGMO), Xilinx (XLNX), Allena Pharmaceuticals (ALNA), Editas Medicine (EDIT) and Maxar Technologies (MAXR).
What is Surgery Partners' stock symbol?: Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY."
Who are Surgery Partners' major shareholders?: Surgery Partners' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Durable Capital Partners LP (6.51%), Clearbridge Investments LLC (6.09%), Avidity Partners Management LP (3.46%), Point72 Asset Management L.P. (2.44%), Dimensional Fund Advisors LP (1.39%) and Geode Capital Management LLC (1.18%). Insiders that own company stock include Anthony Taparo, Bradley R Owens, Brent Turner, Danielle Burkhalter, David T Doherty, George Goodwin, Jason Eric Evans, Jennifer Baldock, Laura L Brocklehurst, Laura L Brocklehurst, Marissa Brittenham, Teresa Deluca, Thomas F Cowhey and Wayne S Deveydt.
View institutional ownership trends.
How do I buy shares of Surgery Partners?: Shares of SGRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Surgery Partners' stock price today?: One share of SGRY stock can currently be purchased for approximately $31.84.
How much money does Surgery Partners make?: Surgery Partners (NASDAQ:SGRY) has a market capitalization of $4.01 billion and generates $2.54 billion in revenue each year. The company earns $-54,600,000.00 in net income (profit) each year or ($0.58) on an earnings per share basis.
How many employees does Surgery Partners have?: The company employs 12,200 workers across the globe.
How can I contact Surgery Partners?: Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The official website for the company is www.surgerypartners.com. The company can be reached via phone at (615) 234-5900, via email at ir@surgerypartners.com, or via fax at 615-234-5998.

This page (NASDAQ:SGRY) was last updated on 3/23/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Surgery Partners - SGRY Stock Forecast, Price & News

Surgery Partners MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Surgery Partners (NASDAQ:SGRY) Stock

SGRY Stock News Headlines

SGRY Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

SGRY Stock - Frequently Asked Questions

Overall MarketRank^™